Affibody Overview

  • Founded
  • 1998
  • Status
  • Private
  • Employees
  • 90
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 1

Affibody General Information


Operator of a private clinical-stage biopharma company intended to develop protein-based drugs. The company engages in research and development of drugs and monoclonal antibodies through its therapeutic programs that target psoriasis, and B-cell drove autoimmune diseases respectively, enabling doctors to get access to therapies that improve the lives of patients with serious diseases

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Scheeles väg 2
  • 171 65 Solna
  • Sweden
+46 08-598 000 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Affibody Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 000.00 Completed Profitable
5. Later Stage VC 08-Mar-2018 000.00 000.00 Completed Profitable
4. Secondary Transaction - Private 01-Jan-2014 000.00 Completed Profitable
3. Later Stage VC 30-Mar-2007 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 03-Oct-2001 $28M $28M Completed Startup
1. Early Stage VC 30-Jun-2000 Completed Startup
To view Affibody’s complete valuation and funding history, request access »

Affibody Executive Team (16)

Name Title Board Seat Contact Info
David Bejker Chief Executive Officer & President
Johan Stuart Chief Financial Officer
Fredrik Frejd Ph.D Chief Scientific Officer
Caroline Ekblad Ph.D Director Alliance and IP Management
Birger Jansson Director, Research
You’re viewing 5 of 16 executive team members. Get the full list »

Affibody Board Members (8)

Name Representing Role Since
Gillian Cannon Affibody Board Member 000 0000
Jakob Lindberg MD Self Board Member 000 0000
Jonathan Knowles Ph.D Self Board Member 000 0000
Jose Suarez Affibody Board Member 000 0000
Robert Burns Affibody Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Affibody Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Affibody Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Investor PE/Buyout Minority 000 0000 000000 0
To view Affibody’s complete investors history, request access »

Affibody Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 29-Jun-2001 000000000000000000 Other Healthcare Technology Systems
To view Affibody’s complete acquisitions history, request access »